RxDoctor Payments Data

Todd Hansen, MD

Family Medicine · Gastonia, NCNPI 1992792642

Payments from drug & device makers

$398in general payments, 2019–2025

Across 19 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$133
  • Novo Nordisk$122
  • Lilly USA, LLC$58
  • Pfizer$54
  • Johnson & Johnson$18
  • Takeda Pharmaceuticals U.S.A., Inc.$13

What the payments were for

  • Food & beverage$398100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$398 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$95,802
Medicare patients
175
Services billed
5,880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide157$180,810
EliquisApixaban384$169,496
MounjaroTirzepatide99$125,234
JardianceEmpagliflozin63$64,675
ArexvyRsvpref3 Antigen/As01e/Pf196$57,964
JanuviaSitagliptin Phosphate108$56,606
XareltoRivaroxaban129$37,713
TrulicityDulaglutide26$24,955
RybelsusSemaglutide12$17,199
Tresiba Flextouch U-200Insulin Degludec20$16,517
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$15,847
Breo ElliptaFluticasone/Vilanterol31$15,843
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,067
JanumetSitagliptin Phos/Metformin Hcl15$12,627
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$11,636

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$122$198,009169 claims
PfizerEliquis, Premarin$54$177,473402 claims
Lilly USA, LLCMounjaro, Trulicity$58$150,189125 claims
Johnson & JohnsonXarelto$18$37,713129 claims
AbbVieLinzess$133$9,77312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →